disopyramide and the class ic agents offer acceptable risk-benefit ratios for the treatment of ventricular tachycardia , whereas no antiarrhythmic drug offers an acceptable risk-benefit for the suppression of asymptomatic `` '' cosmetic '' '' atrial or ventricular ectopic beats .
C0012702
disopyramide
C0003195
antiarrhythmic drug